Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance

Sotera Health (NASDAQ:SHC) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.930-1.010 for the period, compared to the consensus earnings per share estimate of 0.950. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Sotera Health Stock Performance

Shares of SHC traded up $0.36 during mid-day trading on Wednesday, hitting $15.69. 1,433,339 shares of the company’s stock were exchanged, compared to its average volume of 2,570,526. Sotera Health has a 52 week low of $10.80 and a 52 week high of $19.85. The stock’s 50-day simple moving average is $15.00 and its 200-day simple moving average is $16.49. The firm has a market cap of $4.47 billion, a price-to-earnings ratio of 58.17 and a beta of 1.82. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts expect that Sotera Health will post 0.88 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Piper Sandler reiterated an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research note on Wednesday. Barclays cut their target price on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Wells Fargo & Company downgraded Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Finally, Citigroup boosted their price target on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $20.33.

Insider Activity at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction on Friday, March 6th. The stock was sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the sale, the director owned 12,735,301 shares in the company, valued at $194,468,046.27. The trade was a 43.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 15.36% of the company’s stock.

Key Sotera Health News

Here are the key news stories impacting Sotera Health this week:

• Positive Sentiment: Q1 results beat consensus: Sotera reported $0.18 adjusted EPS and $280.05M revenue (up 10% YoY), topping analyst estimates — the official release highlights revenue growth, margin expansion and a return to GAAP net income. Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
• Positive Sentiment: Profitability and cash‑flow metrics improved: Adjusted EBITDA rose ~10.5% and the company moved to positive net income versus a year‑ago loss, supporting margin expansion narratives cited by analysts. Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates
• Positive Sentiment: Company reaffirmed FY2026 outlook and issued EPS guidance of $0.93–$1.01 and revenue guidance roughly $1.2B–$1.3B, signaling management confidence in mid‑single‑digit growth and margin improvement for the year. Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
• Neutral Sentiment: Planned leadership transition announced: Alton Shader will become CEO on May 26, 2026 while current CEO Michael Petras shifts to Executive Chairman — positioned as a planned succession but investors will watch execution risks. Sotera Health Announces Leadership Transition
• Neutral Sentiment: Earnings call and transcripts convey a confident tone and operational momentum; analysts and transcripts note sustained demand in sterilization and testing services but will watch unit volumes and pricing mix. Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Valuation and leverage remain potential headwinds: SHC trades at a high P/E and the company has elevated debt (high debt-to-equity), which could amplify downside if growth or margins disappoint. No article link provided

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in SHC. EverSource Wealth Advisors LLC grew its holdings in Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after acquiring an additional 2,935 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Sotera Health by 736.5% during the fourth quarter. Wells Fargo & Company MN now owns 4,283 shares of the company’s stock worth $76,000 after purchasing an additional 3,771 shares during the period. Quadrant Capital Group LLC bought a new stake in shares of Sotera Health in the third quarter worth $86,000. Los Angeles Capital Management LLC acquired a new stake in Sotera Health in the fourth quarter valued at $90,000. Finally, PNC Financial Services Group Inc. raised its position in Sotera Health by 10.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock worth $127,000 after purchasing an additional 705 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.